Yarward Electronics (Shandong) Past Earnings Performance
Past criteria checks 1/6
Yarward Electronics (Shandong) has been growing earnings at an average annual rate of 21.9%, while the Healthcare Services industry saw earnings declining at 5.4% annually. Revenues have been growing at an average rate of 21.6% per year. Yarward Electronics (Shandong)'s return on equity is 1.6%, and it has net margins of 6%.
Key information
21.9%
Earnings growth rate
-10.0%
EPS growth rate
Healthcare Services Industry Growth | 14.5% |
Revenue growth rate | 21.6% |
Return on equity | 1.6% |
Net Margin | 6.0% |
Last Earnings Update | 30 Jun 2024 |
Revenue & Expenses Breakdown
How Yarward Electronics (Shandong) makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 24 | 292 | 18 | 86 | 45 |
31 Mar 24 | 323 | 33 | 85 | 46 |
31 Dec 23 | 351 | 46 | 82 | 47 |
30 Sep 23 | 362 | 57 | 78 | 49 |
30 Jun 23 | 364 | 70 | 76 | 46 |
31 Mar 23 | 361 | 80 | 71 | 44 |
01 Jan 23 | 353 | 79 | 69 | 42 |
30 Sep 22 | 316 | 74 | 75 | 49 |
30 Jun 22 | 315 | 77 | 85 | 57 |
31 Mar 22 | 282 | 66 | 68 | 48 |
31 Dec 21 | 288 | 73 | 54 | 39 |
31 Dec 20 | 234 | 55 | 49 | 27 |
31 Dec 19 | 165 | 40 | 42 | 20 |
30 Sep 19 | 83 | -10 | 37 | 15 |
30 Jun 19 | -5 | -61 | 25 | 12 |
31 Mar 19 | 64 | -18 | 35 | 15 |
31 Dec 18 | 113 | 15 | 35 | 19 |
30 Sep 18 | 124 | 22 | 41 | 17 |
30 Jun 18 | 115 | 21 | 38 | 15 |
31 Mar 18 | 109 | 22 | 35 | 14 |
31 Dec 17 | 103 | 24 | 32 | 13 |
30 Sep 17 | 107 | 27 | 35 | 9 |
30 Jun 17 | 111 | 30 | 39 | 5 |
31 Mar 17 | 101 | 28 | 39 | 2 |
31 Dec 16 | 90 | 26 | 40 | 0 |
30 Sep 16 | 79 | 21 | 36 | 0 |
30 Jun 16 | 68 | 16 | 33 | 0 |
31 Mar 16 | 66 | 13 | 33 | 0 |
31 Dec 15 | 65 | 11 | 34 | 0 |
Quality Earnings: 301337 has a high level of non-cash earnings.
Growing Profit Margin: 301337's current net profit margins (6%) are lower than last year (19.1%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 301337 has become profitable over the past 5 years, growing earnings by 21.9% per year.
Accelerating Growth: 301337's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 301337 had negative earnings growth (-74.7%) over the past year, making it difficult to compare to the Healthcare Services industry average (11.1%).
Return on Equity
High ROE: 301337's Return on Equity (1.6%) is considered low.